# BIO unveils plan for US to remain biotech’s ‘global leader’

Source: [BioPharma Dive - Latest News](https://www.biopharmadive.com/news/bio-bioadvance-proposal-us-trial-competition-china/874162/) · 2026-11-10 · Medicine
Page: https://themorning.science/story/bio-unveils-plan-for-us-to-remain-biotech-s-global-leader-f4e4ff56ec994a34
Kind: policy · Impact: medium

## In brief

- BIO, a prominent biotech lobbying group, unveiled a seven-part proposal.
- The plan aims to keep the US the leader in biotech and to accelerate drug development in the country.
- The proposal is framed as a response to China's fast rise in biotech.

## Why it matters

The proposal could shape US rules and incentives for drug development and clinical trials, affecting how quickly new therapies reach patients and how the US competes with China in biotech research.

## Timeline

- 2026-11-10: BIO unveiled its seven-part plan to keep the US the global leader in biotech

## Coverage

- [BIO unveils plan for US to remain biotech’s ‘global leader’](https://www.biopharmadive.com/news/bio-bioadvance-proposal-us-trial-competition-china/874162/) — BioPharma Dive - Latest News, 2026-11-10

Tags: biotech, drug-development, clinical-trials, us-policy, china

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science